114 related articles for article (PubMed ID: 788001)
1. [The assessment of neuroleptogenic extrapyramidal syndroms in psychopharmacological research (author's transl)].
Mattke DJ; Mombour W; Glötzner FL
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):36-44. PubMed ID: 788001
[TBL] [Abstract][Full Text] [Related]
2. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
Selman FB; McClure RF; Helwig H
Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
[No Abstract] [Full Text] [Related]
3. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia.
Paprocki J; Versiani M
Curr Ther Res Clin Exp; 1977 Jan; 21(1):80-100. PubMed ID: 12922
[No Abstract] [Full Text] [Related]
4. Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
Tuason VB; Escobar JI; Garvey M; Schiele B
J Clin Psychiatry; 1984 Apr; 45(4):158-63. PubMed ID: 6370967
[TBL] [Abstract][Full Text] [Related]
5. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
Tuason VB
J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
[TBL] [Abstract][Full Text] [Related]
6. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
den Boer JA; Westenberg HG
Psychopharmacol Bull; 1990; 26(1):99-107. PubMed ID: 1973547
[TBL] [Abstract][Full Text] [Related]
7. [Loxapine succinate: a new neuroleptic].
Cottereau MJ; Poirier MF; Lôo H; Deniker P
Encephale; 1979; 5(3):251-67. PubMed ID: 39739
[TBL] [Abstract][Full Text] [Related]
8. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients].
Klieser E; Lehmann E; Tegeler J
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():14-7. PubMed ID: 1683333
[TBL] [Abstract][Full Text] [Related]
9. Loxapine succinate: a controlled double-blind study in chronic schizophrenia.
Schiele BC
Dis Nerv Syst; 1975 Jul; 36(7):361-4. PubMed ID: 1097221
[TBL] [Abstract][Full Text] [Related]
10. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
[TBL] [Abstract][Full Text] [Related]
11. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
Woggon B
Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
[TBL] [Abstract][Full Text] [Related]
12. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
Shopsin B; Pearson E; Gershon S; Collins P
Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
[No Abstract] [Full Text] [Related]
13. Treatment of acute psychotic patients with loxapine parenterally.
Fruensgaard K; Jensen K
Curr Ther Res Clin Exp; 1976 Feb; 19(2):164-9. PubMed ID: 813953
[No Abstract] [Full Text] [Related]
14. Evaluation of loxapine hydrochloride oral concentrate (loxitane C) in acute schizophrenia.
Wittkopp TA
J Clin Psychiatry; 1978 Feb; 39(2):154-7. PubMed ID: 344304
[TBL] [Abstract][Full Text] [Related]
15. Loxapine succinate: a controlled double-blind study in schizophrenia.
Charalampous KD; Freemesser GF; Malev J; Ford K
Curr Ther Res Clin Exp; 1974 Aug; 16(8):829-37. PubMed ID: 4217251
[No Abstract] [Full Text] [Related]
16. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
Hebenstreit GF; Laux G; Schubert H; Beckmann H; Amman J; Bunse J; Eikmeier G; Geretsegger C; Kanitz RD; Kanzow WT
Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
[TBL] [Abstract][Full Text] [Related]
17. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
18. [Extrapyamidal side-effects with 1-day dosage of haloperidol (author's transl)].
Matzner G; Uriarte V; Rüther E
Arzneimittelforschung; 1978; 28(9):1496-7. PubMed ID: 383097
[TBL] [Abstract][Full Text] [Related]
19. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
Eklund K; Forsman A
Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
[TBL] [Abstract][Full Text] [Related]
20. [The significance of standardized evaluation scales in psychiatric diagnosis as exemplified by the therapeutic intervention with desmethyl-loxapine (author's transl)].
Bergener M; Escher HD; Linden KJ
Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):69-81. PubMed ID: 788003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
